Adocia Announces Its Q1 2013 Revenues
4/26/2013 9:05:49 AM
More...
|
Adocia: 2012 Annual Results
3/21/2013 11:56:08 AM
More...
|
Adocia Announces Its Phase III Development Program for the Treatment of Diabetic Foot Ulcer
3/20/2013 10:48:02 AM
More...
|
Adocia is Extending Its Intellectual Property to New Formulations of Monoclonal Antibodies
10/22/2012 11:32:18 AM
More...
|
Adocia: Financial Results and Business Report for the First Half of 2012
9/4/2012 12:18:12 PM
More...
|
Adocia Announces a Strengthened Intellectual Property on Its Lead Project for Its Chronic Wounds Treatment
6/13/2012 11:38:53 AM
More...
|
Adocia: Revenue of First Quarter 2012
4/26/2012 11:26:42 AM
More...
|
Adocia Reports Positive Phase II Clinical Results for the Treatment of Diabetic Foot Ulcer
4/23/2012 1:16:22 PM
More...
|
Adocia Launches Phase 2 Clinical Study on Type 1 Diabetic Patients with its Fast-Acting Human Insulin, Hinsbet(R)
6/24/2011 10:49:46 AM
More...
|